By Mill Chart
Last update: Feb 7, 2024
Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) is suited for growth investing. Investors should of course do their own research, but we spotted AMPHASTAR PHARMACEUTICALS IN showing up in our CANSLIM growth screen, so it may be worth spending some more time on it.
ChartMill assigns a Technical Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple technical indicators and properties.
We assign a technical rating of 4 out of 10 to AMPH. Although AMPH is scoring some points because its good overall performance in the market in the past year, recent evolutions are not that positive. Both the medium and short term picture give negative signs.
Check the latest full technical report of AMPH for a complete technical analysis.
Every day, ChartMill assigns a Fundamental Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various fundamental indicators and properties.
AMPH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 204 industry peers in the Pharmaceuticals industry. While AMPH has a great profitability rating, there are some minor concerns on its financial health. AMPH has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! This makes AMPH very considerable for value and growth investing!
Check the latest full fundamental report of AMPH for a complete fundamental analysis.
Our CANSLIM screen will find you more ideas suited for growth investing.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
28.43
-3.06 (-9.72%)
Find more stocks in the Stock Screener
AMPHASTAR PHARMACEUTICALS IN is a hidden gem, featuring undervaluation and robust fundamentals. NASDAQ:AMPH showcases decent financial health and profitability, coupled with an attractive price.